Meta-Analysis of 51 Cohorts Finds Each 100g Daily UPF Increase Raises Cardiovascular Event Risk by 14%

The Family Medicine and Community Health pooled analysis converted daily UPF intake into 50g servings across food-frequency and 24-hour recall data spanning 2–32 years. Risks rose linearly: high consumers showed 24% greater cardiovascular events, 24% metabolic syndrome/diabetes, 31% digestive disease, and 18% all-cause mortality. Each 10% energy contribution from UPF added 16% diabetes risk. These gradients persisted after adjustment for age, sex, and smoking but could not fully isolate correlated behaviors such as lower physical activity.

Processing-related mechanisms include acrylamide formation, acrolein from heated fats, and additive mixtures that alter gut microbiota and promote insulin resistance, consistent with findings from a 2023 Lancet Public Health review of mechanistic trials. Observational designs cannot exclude residual confounding from socioeconomic status or overall diet quality, yet the dose-response pattern across continents and the exclusion of participants under 18 strengthen causal plausibility.

Future work requires randomized substitution trials measuring hard endpoints and longer microbiome follow-up to test whether reformulation or taxation thresholds reduce incidence. Regulatory agencies are already modeling such data for front-of-pack labeling.